Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
复制标题
非典型泛素 E3 连接酶复合体 Skp1-Pam-Fbxo45 控制核心上皮间质转化诱导转录因子
DOI:
10.18632/oncotarget.2825
复制
发表时间:
2015-01-20
期刊:
影响因子:
--
通讯作者:
Yu J
中科院分区:
文献类型:
--
作者:
Xu M;Zhu C;Zhao X;Chen C;Zhang H;Yuan H;Deng R;Dou J;Wang Y;Huang J;Chen Q;Jiang B;Yu J
Epithelial-mesenchymal transition (EMT) plays a critical role in the development of tumor metastases by enhancing migration/invasion. One of the hallmarks of EMT is loss of E-cadherin and gain of N-cadherin expression, which are regulated by the core EMT-inducing transcription factors (EMT-TFs), such as Zeb1/2, Snai1/2 and Twist1. Here, we find that EMT-TFs can be dynamically degraded by an atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 (SPFFbxo45) through the ubiquitin proteasome system (UPS). The key step is recognition of EMT-TFs by Fbxo45 through its SPRY domain for Zeb2, or F-box domain for the other three EMT-TFs Snai1, Snai2 and Twist1, respectively. The K48-linkaged ubiquitination capability on Zeb2 relies on its functional SBD domain. In addition, miR-27a* can directly down-regulate the expression of Fbxo45, preventing degradation of EMT-TFs and thus ensuring EMT phenotype. We suggest that Fbxo45 is a key node of the miR-27a*/Fbxo45/EMT-TFs signaling axis.
登录
查看更多内容
影响因子:
6.4
作者:
BAE, VL;JACKSONCOOK, CK;WARE, JL
通讯作者:
WARE, JL
影响因子:
11.2
作者:
Casas E;Kim J;Bendesky A;Ohno-Machado L;Wolfe CJ;Yang J
通讯作者:
Yang J
影响因子:
11.1
作者:
Miguel Lopez-Novoa, Jose;Angela Nieto, M.
通讯作者:
Angela Nieto, M.
影响因子:
15.9
作者:
Kuo, Tsang-Chih;Tan, Ching-Ting;Kuo, Min-Liang
通讯作者:
Kuo, Min-Liang
影响因子:
20.3
作者:
Goossens, Steven;Janzen, Viktor;Haigh, Jody J.
通讯作者:
Haigh, Jody J.